Latest Close
$9.71
News
CRBP
Corbus Pharmaceuticals Holdings News
This news view pulls recent coverage and headlines tied to CRBP.
1y Change
$4.04 (+71.25%)
Market Cap
$174,526,816.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
GlobeNewswire • Apr 7, 2026
Read articleMizuho Lifts Price Target on Corbus Pharmaceuticals Holdings to $40 From $39, Keeps Outperform Rating
MT Newswires • Apr 2, 2026
Read articleCorbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
GlobeNewswire • Mar 18, 2026
Read articleHow Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33%
Zacks • Mar 11, 2026
Read articleCorbus Pharmaceuticals: Q4 Earnings Snapshot
Associated Press Finance • Mar 9, 2026
Read articleCorbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update
GlobeNewswire • Mar 9, 2026
Read article